- The total sales turnover Indian Pharmaceuticals products in the year 2012-13 was about Rs.1,20,000 crore which mainly consist of largely generics medicines.
- It was stated by the Minister for Chemicals & fertilizers Shri Srikant Kumar Jena in Lok Sabha on Tuesday.
- As per Minister statement the total sales turnover of Indian Pharmaceuticals products, which are largely generics, was about Rs.1,20,000 crore in the year 2012-13.
- Indian Pharmaceutical market is mostly of generic medicines.
- The patented medicines have no generic versions.
- The Minister said that a Price Negotiation mechanisms Committee was set up for patented drugs .
- The Committee’s report was put on the public domain for wider publicity for inviting comments from stakeholders, Observing the diverse opinion of different stakeholders received by the Government, an Inter-ministerial Committee of Joint Secretaries to look into the issues and to suggest ways and means to fix the prices of patented drugs in the country has been formed.
Pages
- Home
- Editorial
- Article
- General Studies-History
- Current affairs
- General Studies-Polity
- UPSC Videos
- CSAT-2
- ESSAY
- Economics
- Environment
- gsmains
- Mains Q & A series
- Study Material
- Mock Questions for GS Mains
- GK Series
- MPSC
- MBA
- Public Administration
- General Studies-II
- General Studies-I
- UPSC Prelims 2014
- General Studies-III
- INDIA YEAR BOOK
- संपादकीय
Wednesday, February 19, 2014
Generic Medicines Rule Over Rs.1,20,000 crore Indian Pharmaceuticals Market: Government
Labels:
Current affairs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment